MECHANISMS OF SPONTANEOUS AND INDUCED HETEROPLOIDIZATION AND POLYPLOIDIZATION.PALYI I.1976; ACTA MORPHOL. ACAD. SCI. HUNGAR.; HONGR.; DA. 1976 PARU 1977; VOL. 24; NO 4; PP. 307-315; ABS. ALLEM. RUSSE; BIBL. 21 REF.Article

SURVIVAL AND PHASE SENSITIVITY OF HELA CELLS TREATED WITH DIANHYDROGALACTITOL (NSC-132313).PALYI I.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 3; PP. 493-499; BIBL. 21 REF.Article

Survival responses to new cytostatic hexitols of P388 mouse and K562 human leukemia cells in vitroPALYI, I.Cancer treatment reports. 1986, Vol 70, Num 2, pp 279-284, issn 0361-5960Article

EFFECTS OF CYTOSTATICS ON PROLIFERATING AND STATIONARY CULTURES OF MAMMALIAN CELLS.OLAH E; PALYI I; SUGAR J et al.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 8; PP. 895-900; BIBL. 21 REF.Article

THE MODE OF ACTION OF VINCA ALKALOIDSCSUKA O; SUGAR J; PALYI I et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 82-87; BIBL. 8 REF.Article

Benzamide potentiation of the cytotoxicity of bifunctional galacticol in resistant P388 leukemia correlates with inhibition of DNA ligase IIINSTITORIS, E; FOX, B. W; PALYI, I et al.Cancer chemotherapy and pharmacology. 1992, Vol 30, Num 4, pp 325-329, issn 0344-5704Article

Dominance of resistance to the alkylating agent 1,2: 5,6-dianhydro-galactilol in P388 mouse lymphoma hybrid cellsPALYI, I; BENCE, J; SZIKLA, K et al.Cancer chemotherapy and pharmacology. 1989, Vol 23, Num 1, pp 41-46, issn 0344-5704Article

Bullöses Pemphigoid bei einem Patienten mit multipler Sklerose und Psoriasis = Bullous pemphigoid in a patient with multiple sclerosis and psoriasis vulgarisRACZ, A; NAGY, E; PALYI, I et al.H + G. Zeitschrift für Hautkrankheiten. 2000, Vol 75, Num 6, pp 369-372, issn 0301-0481Article

Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)PALYI, I; PETER, I; DAUBNER, D et al.Virchows Archiv. B, Cell pathology. 1993, Vol 63, Num 4, pp 263-269, issn 0340-6075Article

Dominant expression of multidrug resistance in intraspecific murine lymphoma hybrid cellsPALYI, I; TURI, G; HULLAN, L et al.Cancer chemotherapy and pharmacology. 1994, Vol 34, Num 1, pp 81-85, issn 0344-5704Article

Synthesis of new poly(N-vinyl pyrrolidone-co-maleic acid) : Peptide hormone conjugates with anticancer activityPATO, J; MORA, M; MEZO, I et al.Journal of bioactive and compatible polymers. 1999, Vol 14, Num 4, pp 304-314, issn 0883-9115Article

Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenograftsKREMMER, T; PALYI, I; DAUBNER, D et al.Anticancer research. 1991, Vol 11, Num 5, pp 1807-1813, issn 0250-7005Article

Influence of luteinizing hormone-releasing hormone agonists on human mammary carcinoma cell lines and their xenograftsVINCZE, B; PALYI, I; ECKHARDT, S et al.Journal of steroid biochemistry and molecular biology. 1991, Vol 38, Num 2, pp 119-126, issn 0960-0760, 8 p.Article

Synthesis of gonadotropin-releasing hormone III analogs. Structure-Antitumor activity relationshipsMEZÖ, I; LOVAS, S; GULYAS, E et al.Journal of medicinal chemistry (Print). 1997, Vol 40, Num 21, pp 3353-3358, issn 0022-2623Article